First AD

Second AD

Medical Content

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

The Evolving Field of Biomarker Testing in Solid Tumors

Peer Exchange

Gregory Vidal, MD, PhD, highlights the benefits and drawbacks of the available biomarker testing options and how the results guide treatment decision-making.

Using Molecular Testing to Guide Treatment Decisions

Available Molecular Tests for Solid Tumors 

PD-L1 Expression and IO Therapy in Lung and Breast Cancer

Clinical Scenario: A 44-Year-Woman with Metastatic Breast Cancer

Currently Targetable Mutations in Lung and Breast Cancer

Choosing a Molecular Testing Panel for Solid Tumors

Biomarker Testing Interpretation in Breast and Lung Cancer

Challenges of Biomarker Testing in Breast Cancer

Use of Liquid Biopsies in Breast Cancer

Discussing Biomarker Testing with Patients

Biomarker-Influenced Treatment Approaches for Patients with Metastatic Lung Cancer

Clinical Scenario: A 74-Year-Old Man with Lung Cancer

Further Molecular Testing in Early-Stage Metastatic Breast Cancer

Targeted Therapy in Metastatic Breast Cancer for Patients with BRCA Mutations

Monitoring Patients on First-Line Treatment for Metastatic Breast Cancer 

Biomarker Testing Standards-of-Care in Breast and Lung Cancer